Osaic Holdings
CPRX

Osaic Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Osaic Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Sell
13,763
-3,125
-19% -$92.2K ﹤0.01% 3780
2026
Q1 		$418K Sell
16,888
-646
-4% -$15.4K ﹤0.01% 3526
2025
Q4 		$409K Sell
17,534
-8,346
-32% -$186K ﹤0.01% 3516
2025
Q3 		$527K Sell
25,880
-18,393
-42% -$378K ﹤0.01% 3385
2025
Q2 		$1.01M Buy
44,273
+33,314
+304% +$786K ﹤0.01% 2503
2025
Q1 		$266K Sell
10,959
-3,711
-25% -$83.6K ﹤0.01% 3410
2024
Q4 		$306K Sell
14,670
-4,764
-25% -$102K ﹤0.01% 3214
2024
Q3 		$386K Sell
19,434
-3,901
-17% -$72.3K ﹤0.01% 3104
2024
Q2 		$361K Sell
23,335
-2,726
-10% -$42.4K ﹤0.01% 3045
2024
Q1 		$415K Sell
26,061
-28,318
-52% -$427K ﹤0.01% 3083
2023
Q4 		$914K Sell
54,379
-14,619
-21% -$200K ﹤0.01% 2603
2023
Q3 		$807K Buy
68,998
+33,086
+92% +$443K ﹤0.01% 2831
2023
Q2 		$483K Sell
35,912
-10,867
-23% -$156K ﹤0.01% 3181
2023
Q1 		$776K Buy
46,779
+15,737
+51% +$260K ﹤0.01% 2718
2022
Q4 		$577K Buy
31,042
+7,456
+32% +$115K ﹤0.01% 2895
2022
Q3 		$302K Buy
23,586
+21,882
+1,284% +$259K ﹤0.01% 3377
2022
Q2 		$12K Buy
1,704
+507
+42% +$3.72K ﹤0.01% 5950
2022
Q1 		$10K Buy
1,197
+29
+2% +$205 ﹤0.01% 6115
2021
Q4 		$8K Sell
1,168
-94
-7% -$618 ﹤0.01% 6392
2021
Q3 		$7K Buy
1,262
+152
+14% +$831 ﹤0.01% 6375
2021
Q2 		$6K Buy
1,110
+191
+21% +$986 ﹤0.01% 6285
2021
Q1 		$4K Buy
919
+719
+360% +$2.86K ﹤0.01% 6246
2020
Q4 		$1K Sell
200
-1,900
-90% -$6.38K ﹤0.01% 6188
2020
Q3 		$7K Buy
2,100
+1,400
+200% +$5.47K ﹤0.01% 5432
2020
Q2 		$3K Sell
700
-300
-30% -$1.35K ﹤0.01% 5643
2020
Q1 		$4K Buy
+1,000
New +$4.11K ﹤0.01% 5425

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's CPRX Position: Q2 2026 in Review

Osaic Holdings reduced its Catalyst Pharmaceutical (CPRX) stake by 19% in Q2 2026, selling an estimated $92.2K and leaving 13,763 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Osaic Holdings first reported a position in CPRX in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.01M in Q2 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Osaic Holdings held 13,763 shares of Catalyst Pharmaceutical worth $432K as of Q2 2026.
  • Osaic Holdings sold 3,125 Catalyst Pharmaceutical shares in Q2 2026, an estimated $92.2K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3780 holding.
  • Osaic Holdings first reported a position in Catalyst Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Catalyst Pharmaceutical position peaked at $1.01M in Q2 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.